Clinical features, risk factors, and antimicrobial resistance of pseudomonas putida isolates

Basit Öğe Kaydı
dc.contributor.authorBaykal, Hüsnü
dc.contributor.authorÇelik, Deniz
dc.contributor.authorÜlger, A. Füsun
dc.contributor.authorVezir, Sedat
dc.contributor.authorGüngör, M. Ömür
dc.date.accessioned2023-07-31T13:11:30Z
dc.date.available2023-07-31T13:11:30Z
dc.date.issued2022
dc.departmentALKÜ, Fakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü
dc.description.abstractPseudomonas putida rarely results in infection, primarily in patients undergoing invasive procedures or immunocompromised hosts. We aimed to investigate the characteristics of Pseudomonas putida infections. This is a retrospectively designed cross-sectional observational study. We retrospectively scanned the data from our hospital for the 10 years before February 15, 2022. The patients with Pseudomonas putida growth in the microbiological cultures and with antibiotic susceptibility tests were included in the study. We recorded culture isolates types, age, gender, comorbidities, immunosuppressive factors, symptoms, invasive medical procedures, length of hospital stay, and radiological findings. The mean age of the patients was 66.2?±?14.5 years, and the male patients predominated (76.3%, n?=?58/76). There was growth in bronchial lavage in 33 patients, sputum in 28, pleural effusion fluid in 12, and tracheal aspirate in 3 patients. The rate of antibiotic-resistant strains was 56.6% (n?=?43). All strains were sensitive to colistin (100%), and carbapenem, amikacin, and gentamicin sensitivity rates were high. We observed that the risk of antibiotic resistance increased 4.29 times in the patients in the intensive care unit (Cl:1.27–14.47, P?=?.01). The patients with Diabetes Mellitus had a higher risk (OR 4.33, Cl:1.11–16.77, P?=?.03), and in cancer cases, the risk was 3.31 times higher (Cl:1.06–10.32, P?=?.03). The risk of Pseudomonas putida infection should be considered, particularly in patients with comorbid disorders causing immunosuppression, including Diabetes Mellitus and Cancer.
dc.identifier.doi10.1097/MD.0000000000032145
dc.identifier.issue48en_US
dc.identifier.scopusqualityN/A
dc.identifier.urihttps://www.scopus.com/record/display.uri?eid=2-s2.0-85143569948&origin=resultslist&sort=plf-f&src=s&nlo=&nlr=&nls=&sid=20c4fe371b9b908d4f7e419f791331ff&sot=aff&sdt=cl&cluster=scofreetoread%2c%22all%22%2ct&sl=72&s=AF-ID%28%22Alanya+Alaaddin+Keykubat+University%22+60198720%29+AND+SUBJAREA%28MEDI%29&relpos=31&citeCnt=0&searchTerm=
dc.identifier.urihttps://hdl.handle.net/20.500.12868/2344
dc.identifier.urihttps://journals.lww.com/md-journal/fulltext/2022/12020/clinical_features,_risk_factors,_and_antimicrobial.132.aspx
dc.identifier.volume101en_US
dc.indekslendigikaynakScopus
dc.language.isoen
dc.relation.ispartof10
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectAntibiotic resistance
dc.subjectImmunosuppression
dc.subjectInvasive procedures
dc.subjectPseudomonas putida
dc.titleClinical features, risk factors, and antimicrobial resistance of pseudomonas putida isolates
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Clinical_features,_risk_factors,_and_antimicrobial.132.pdf
Boyut:
557.54 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu